CERA.NS(CERA.NS)
CERA.NS
No analyst ratings available
No analyst price targets available for CERA.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $23.35B | $26.04B | $28.46B |
| Low | $22.88B | $24.68B | $27.41B |
| High | $24.49B | $27.62B | $30.03B |
| EBITDA Avg | $3.99B | $4.45B | $4.87B |
| Low | $3.91B | $4.22B | $4.69B |
| High | $4.19B | $4.72B | $5.13B |
| EBIT Avg | $3.53B | $3.93B | $4.30B |
| Low | $3.46B | $3.73B | $4.14B |
| High | $3.70B | $4.17B | $4.54B |
| Net Income Avg | $2.61B | $3.03B | $3.52B |
| Low | $2.36B | $2.60B | $3.35B |
| High | $2.85B | $3.31B | $3.77B |
| EPS Avg | $202.05 | $235.23 | $272.75 |
| Low | $183.29 | $201.20 | $259.63 |
| High | $221.09 | $256.83 | $292.26 |
| Analysts (Rev / EPS) | 13 / 12 | 13 / 12 | 9 / 10 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $5.51B | $5.66B | $7.40B |
| Low | $5.51B | $5.66B | $7.40B |
| High | $5.51B | $5.66B | $7.40B |
| EBITDA Avg | $941M | $968M | $1.27B |
| Low | $941M | $968M | $1.27B |
| High | $941M | $968M | $1.27B |
| EBIT Avg | $832M | $856M | $1.12B |
| Low | $832M | $856M | $1.12B |
| High | $832M | $856M | $1.12B |
| Net Income Avg | $596M | $618M | $814M |
| Low | $596M | $618M | $814M |
| High | $596M | $618M | $814M |
| EPS Avg | $46.20 | $47.90 | $63.10 |
| Low | $46.20 | $47.90 | $63.10 |
| High | $46.20 | $47.90 | $63.10 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |